LUND, SWEDEN -- (MARKET WIRE) -- March 28, 2007 -- The Board of Directors of Active Biotech decided in February 2007 to exercise the entitlement to request premature repayment of a convertible loan raised in 2004 through the issue of the 2004/2009 convertible debentures.
